Economic modelling of antiplatelet therapy in the secondary prevention of stroke

JOURNAL ARTICLE published January 2004 in Journal of Medical Economics

Authors: Stephen M Beard | Louise Gaffney | Luke Bamber | Jason De Platchett

Preeclampsia in Switzerland: a cost analysis in two hospitals

JOURNAL ARTICLE published 1 September 2020 in Journal of Medical Economics

Authors: Markus Hodel | Patricia R. Blank | Petra Marty | Olav Lapaire

Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritis

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: Ervant J. Maksabedian Hernandez | Isabelle Tingzon | Lorenzo Ampil | Jessica Tiu

Biomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage

JOURNAL ARTICLE published 1 September 2020 in Journal of Medical Economics

Authors: Maurizio Benucci | Maria Infantino | Mariangela Manfredi

The economic advantages of response in the treatment of advanced breast cancer

JOURNAL ARTICLE published January 1999 in Journal of Medical Economics

Authors: Ruth E Brown | Anita Burrell

A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis

JOURNAL ARTICLE published 2 June 2020 in Journal of Medical Economics

Authors: Sang Hee Park | Xue Han | Francis Lobo | David Kratochvil | Dipen Patel

Costs of hospital events in patients with metastatic colorectal cancer

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Jetty A. Overbeek | Zhongyun Zhao | Myrthe P. P. van Herk-Sukel | Beth L. Barber | Sue Gao | Ron M. C. Herings

Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study

JOURNAL ARTICLE published March 2014 in Journal of Medical Economics

Authors: Josep Darbà | Lisette Kaskens | Rainel Sánchez-de la Rosa

Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn’s disease using real world evidence in Thailand

JOURNAL ARTICLE published 1 November 2020 in Journal of Medical Economics

Research funded by Thai Food and Drug Administration (Thai FDA), Ministry of Public Health (119/2562,249/2562)

Authors: Pochamana Phisalprapa | Chayanis Kositamongkol | Julajak Limsrivilai | Satimai Aniwan | Phunchai Charatcharoenwitthaya | Pises Pisespongsa | Taya Kitiyakara | Suporn Treepongkaruna | Nathorn Chaiyakunapruk

Surgical procedures and their cost estimates among women with newly diagnosed endometriosis: a US database study

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: M. Fuldeore | K. Chwalisz | S. Marx | N. Wu | L. Boulanger | L. Ma | K. Lamothe

Clopidogrel: a pharmacoeconomic review

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Nowwar Mustafa | William Weintraub

One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel

JOURNAL ARTICLE published December 2012 in Journal of Medical Economics

Authors: Tanya M. Burton | Michael Lacey | Fang Liu | Yanni Yu | Maria Laura Monsalvo | Kathy Lang | Stephen Sander

Use of distance learning to teach discrete event simulation

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Benjamin Hunting | Jorgen Moller | Ingrid Caro | J Jaime Caro

Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States

JOURNAL ARTICLE published February 2013 in Journal of Medical Economics

Authors: Myrlene Sanon | Douglas C.A. Taylor | Anju Parthan | John Coombs | Marc Paolantonio | Medha Sasane

Improvement of headache symptoms and reduction in headache medication usage in patients treated with botulinum toxin type A

JOURNAL ARTICLE published January 2004 in Journal of Medical Economics

Authors: Peter McAllister

Letter to the Editor: Author Response

JOURNAL ARTICLE published June 2014 in Journal of Medical Economics

Authors: Tamlyn Rautenberg

Correction

JOURNAL ARTICLE published 2 December 2018 in Journal of Medical Economics

Cost and clinical consequences of stress/single-photon emission computed tomography testing with specific medications

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Onur Baser | James Spalding | Smita Kothari | Huseyin Yuce | Maria Laura Monsalvo

A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective

JOURNAL ARTICLE published March 2010 in Journal of Medical Economics

Authors: Nic Brereton | Keith Bodger | Michael A. Kamm | Paul Hodgkins | Songkai Yan | Ron Akehurst

Health economic comparisons of rofecoxib versus conventional nonsteroidal antiinflammatory drugs for osteoarthritis in the United Kingdom

JOURNAL ARTICLE published January 2001 in Journal of Medical Economics

Authors: R Andrew Moore | Ceri J Phillips | James M Pellissier | Sheldon X Kong